On March 2, 2023, ZYUS Life Sciences Corporation closed the transaction. The company has received $18,557. The transaction included participation from a single investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 CAD | -4.55% | -2.78% | +16.67% |
07/05 | ZYUS Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
23/04 | ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate | MT |
1st Jan change | Capi. | |
---|---|---|
+16.67% | 54.41M | |
+65.25% | 62.59B | |
-1.27% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.34% | 26.21B | |
-21.77% | 19.09B | |
+4.92% | 13.08B | |
+25.53% | 12.26B | |
+28.61% | 12.05B |
- Stock Market
- Equities
- ZYUS Stock
- News ZYUS Life Sciences Corporation
- ZYUS Life Sciences Corporation announced that it has received $0.018557 million in funding